We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

21 hedge funds and large institutions have $30M invested in Aldeyra Therapeutics in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $25.2M → $30M (+$4.78M)

5% less funds holding

Funds holding: 22 → 21 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
Perceptive Advisors
New York
+$1.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$74.4K
3
BFA
BlackRock Fund Advisors
California
+$5.25K

Top Sellers

1
SM
Sabby Management
Florida
-$446K
2
JP Morgan Chase
JP Morgan Chase
New York
-$371K
3
NIP
Nicholas Investment Partners
California
-$371K
4
SFM
Sphera Funds Management
Israel
-$178K
5
SIM
Spark Investment Management
New York
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$9.75M – – –
PA
2
Perceptive Advisors
New York
$8.41M +$1.9M +283,265 +30%
DM
3
Deerfield Management
New York
$4.68M – – –
SFM
4
Sphera Funds Management
Israel
$1.62M -$178K -26,500 -10%
BBA
5
Baker Bros. Advisors
New York
$963K – – –
KCM
6
Knoll Capital Management
Florida
$921K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$802K +$74.4K +11,070 +10%
Millennium Management
8
Millennium Management
New York
$746K -$40.8K -6,076 -5%
WMSA
9
Weiss Multi-Strategy Advisers
New York
$515K – – –
SM
10
Sabby Management
Florida
$466K -$446K -66,298 -49%
BC
11
Boxer Capital
California
$428K +$424K +63,146 New
PVI
12
Pura Vida Investments
New York
$390K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$152K – – –
Northern Trust
14
Northern Trust
Illinois
$83K – – –
Morgan Stanley
15
Morgan Stanley
New York
$49K -$89.2K -13,274 -65%
BA
16
BlackRock Advisors
Delaware
$20K – – –
VIA
17
Vantage Investment Advisors
Pennsylvania
$14K – – –
BIM
18
BlackRock Investment Management
Delaware
$6K – – –
BFA
19
BlackRock Fund Advisors
California
$5K +$5.25K +781 New
TRCT
20
Tower Research Capital (TRC)
New York
$1K -$7.72K -1,149 -88%
NIP
21
Nicholas Investment Partners
California
– -$371K -63,666 Closed
JP Morgan Chase
22
JP Morgan Chase
New York
– -$371K -63,605 Closed
SIM
23
Spark Investment Management
New York
– -$105K -18,400 Closed
UBS Group
24
UBS Group
Switzerland
– -$10.2K -1,520 -96%

ALDX Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q4 2015, worth a combined $30M — up 19% from $25.2M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ALDX and 2 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 2 added.

The largest buyer was Perceptive Advisors, adding an estimated $1.9M. The largest seller was Sabby Management, cutting an estimated $446K.

  • 21 institutional investors held Aldeyra Therapeutics (ALDX) as of Q4 2015, down from 22 in Q3 2015.
  • Funds reported $30M of Aldeyra Therapeutics stock for Q4 2015, up 19% quarter-over-quarter.
  • 2 funds opened new Aldeyra Therapeutics positions in Q4 2015 and 3 closed out, a net change of -1 holder.
  • The largest Aldeyra Therapeutics buyer in Q4 2015 was Perceptive Advisors, an estimated $1.9M added.
  • The largest Aldeyra Therapeutics seller in Q4 2015 was Sabby Management, an estimated $446K sold.

Based on aggregated 13F filings for Q4 2015.